Canada markets open in 7 hours 5 minutes
  • S&P/TSX

    20,144.04
    -86.92 (-0.43%)
     
  • S&P 500

    4,221.86
    -1.84 (-0.04%)
     
  • DOW

    33,823.45
    -210.22 (-0.62%)
     
  • CAD/USD

    0.8083
    -0.0010 (-0.13%)
     
  • CRUDE OIL

    70.75
    -0.29 (-0.41%)
     
  • BTC-CAD

    46,423.05
    -1,964.11 (-4.06%)
     
  • CMC Crypto 200

    933.76
    -36.11 (-3.72%)
     
  • GOLD FUTURES

    1,784.90
    +10.10 (+0.57%)
     
  • RUSSELL 2000

    2,287.46
    -27.23 (-1.18%)
     
  • 10-Yr Bond

    1.5110
    0.0000 (0.00%)
     
  • NASDAQ futures

    14,203.75
    +38.25 (+0.27%)
     
  • VOLATILITY

    17.75
    -0.40 (-2.20%)
     
  • FTSE

    7,153.43
    -31.52 (-0.44%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • CAD/EUR

    0.6788
    -0.0006 (-0.09%)
     

NeuBase: Fiscal Q2 Earnings Snapshot

PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $5.5 million in its fiscal second quarter.

On a per-share basis, the Pittsburgh-based company said it had a loss of 24 cents.

In the final minutes of trading on Thursday, the company's shares hit $4.64. A year ago, they were trading at $8.69.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting